Featured
Want to learn more about Clinical Trials Workshop II - Translating the New Transparency Requirements into Practice? You've come to the right site!
Program Committee
-
Sabine Atzor, MPHARM, RPH Head of EU Regulatory Policies
F. Hoffmann-La Roche Ltd, Switzerland -
Nick Sykes, MS Policy Advisor, Regulatory Strategy
EFPIA, Belgium -
Merete Joergensen, MBA, MSC Clinical Disclosure and Transparency Expert
Merete-J Consulting, Denmark -
Hanns-Georg Leimer, PHD Global Head Central Solutions and Services Medicine (CSSM) in Global Biostatisti
Boehringer Ingelheim Pharma GmbH&CO KG, Germany -
Robert Paarlberg, MS Principal
Paarlberg & Associates LLC, United States
Have an account?